Parkside Financial Bank & Trust Sarepta Therapeutics, Inc. Transaction History

Parkside Financial Bank & Trust

$702 Million
Q3 2024

A detailed history of Parkside Financial Bank & Trust transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 13 shares of SRPT stock, worth $1,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 13 -0.0%

Holding current value

$1,441

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$113.33 - $163.85 $3,626 - $5,243	-32 Reduced 71.11%	13 $2,000
Q1 2024 May 01, 2024	BUY	$93.7 - $141.53 $2,529 - $3,821	27 Added 150.0%	45 $5,000
Q4 2023 Feb 01, 2024	BUY	$67.31 - $124.76 $673 - $1,247	10 Added 125.0%	18 $1,000
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $102 - $123	1 Added 14.29%	8 $0
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $706 - $924	7 New	7 $0
Q2 2022 Jul 13, 2022	SELL	$62.69 - $88.44 $1,316 - $1,857	-21 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $3,410 - $4,882	-54 Reduced 72.0%	21 $2,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $309 - $397	-4 Reduced 5.06%	75 $7,000
Q3 2021 Oct 29, 2021	BUY	$65.97 - $92.48 $3,364 - $4,716	51 Added 182.14%	79 $7,000
Q2 2021 Aug 06, 2021	BUY	$69.38 - $86.75 $1,387 - $1,735	20 Added 250.0%	28 $2,000
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $361 - $844	5 Added 166.67%	8 $1,000
Q4 2020 Feb 09, 2021	SELL	$125.56 - $178.74 $2,260 - $3,217	-18 Reduced 85.71%	3 $1,000
Q3 2020 Nov 06, 2020	BUY	$127.12 - $172.34 $762 - $1,034	6 Added 40.0%	21 $3,000
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $2,046 - $3,777	-22 Reduced 59.46%	15 $2,000
Q1 2020 May 05, 2020	SELL	$82.38 - $131.64 $1,565 - $2,501	-19 Reduced 33.93%	37 $4,000
Q3 2019 Nov 05, 2019	SELL	$72.81 - $156.91 $5,533 - $11,925	-76 Reduced 57.58%	56 $4,000
Q1 2019 May 01, 2019	BUY	$106.67 - $151.68 $6,400 - $9,100	60 Added 83.33%	132 $16,000
Q4 2018 Jan 31, 2019	SELL	$97.32 - $148.76 $389 - $595	-4 Reduced 5.26%	72 $8,000
Q4 2017 Feb 05, 2018	SELL	$47.64 - $56.75 $428 - $510	-9 Reduced 10.59%	76 $4,000
Q3 2017 Oct 27, 2017	BUY	$35.73 - $47.15 $3,037 - $4,007	85	85 $4,000

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.71B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Sarepta Therapeutics, Inc. Transaction History